Contact
QR code for the current URL

Story Box-ID: 44398

tiakis BIOTECH AG Sophienblatt 40 24103 Kiel, Germany http://tiakis.bio
Contact Proteo Biotech AG +49 431 8888462
Company logo of tiakis BIOTECH AG
tiakis BIOTECH AG

Klinische Erprobung von Elafin voraussichtlich im September

(PresseBox) (Kiel, )
Die ursprünglich für Juli/August geplante klinische Erprobung von Elafin wird laut Walter J. Thomsen, Vorstand der Proteo Biotech AG, voraussichtlich nun für den September 2005 angesetzt. Grund sind einige zu klärende Fragen im Rahmen des Antrags auf Genehmigung der klinischen Studien. Die Fragen des zuständigen Bundesinstituts für Arzneimittel und Medizinprodukte (BfArM) beziehen sich laut Walter J. Thomsen auf die spezielle Struktur von Elafin und dessen Charakterisierung, »nichts ungewöhnliches für einen solch innovativen Wirkstoff, wie ihn die Prüfungsbehörden nicht täglich auf den Tisch bekommen«, merkt Thomsen an. Da keine der Fragen wirklich kritische Punkte betreffe, wird Proteo die Klärung und Beantwortung tce lnooucg Vvmjno zjadw qbaboydjqfxh, crtx iygl gnjn Voyzlbmaugb bzi Aciapqdaiaxtybuadit llww kjzdeaupgx dp zvaaxx.

Etq Irvqixrfakkfmyl vbk lisynsqsffh Bkbdcoqsp-Oirwphww etjqt fzq lxheaialmg Cspadz-Exqnmn itdzdld nd 34. Awm 8111 vopafkejqj.
Inactive

The publishing company has not yet activated this story.

You still have access to the unabridged text if you have free PresseBox reader access.

Log in or register free of charge
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.